Current Health Selects VivaLNK Wearable Temperature Sensor for Remote Patient Monitoring

CAMPBELL, Calif., May 14, 2020 /PRNewswire/ — VivaLNK, a leading provider of connected healthcare solutions, today announces Current Health has selected VivaLNK’s continuous temperature sensor for its AI-powered remote patient monitoring (RPM) solution. The solution is designed to reduce hospital overcrowding and readmissions by allowing patient vitals and conditions to be monitored at home.

The Current Health solution monitors multiple vital signs using an AI engine to determine health conditions and situations which may warrant medical intervention. In the case of infectious diseases, or procedures such as chemotherapy and surgery, the use of a continuous temperature sensor is critical to spotting infections that may require hospitalization.

With COVID-19, patients who have a confirmed diagnosis or who are symptomatic, but not serious enough for hospital admission, can be quarantined at home while still being monitored remotely by medical professionals.

Instead of relying on the patient to manually measure and report temperature multiple times per day, the medical grade VivaLNK continuous temperature sensor does this automatically by sending patient temperature to the Current Health system on a continuous basis even while the patient is asleep. This stream of data can present a more accurate picture and trend on the condition of the patient.

“Requiring patients to manually take temperature readings throughout the day is not only cumbersome, but can also result in data omissions due to forgetfulness,” said Chris McCann, CEO and Founder, Current Health. “With VivaLNK’s continuous temperature sensor, the data is automatically captured 24 hours a day, allowing our solution to provide a more complete and accurate picture of the patient’s condition.”

For more information on the VivaLNK temperature sensor visit https://www.vivalnk.com/product/temperature-sensor.

About VivaLNK

VivaLNK is a provider of connected healthcare solutions for patient care and telemedicine. The company’s portfolio includes wearable medical grade devices and data analytics applications that continuously monitor the health and well-being of individuals. The company’s vision is to improve the quality and accessibility of healthcare worldwide by combining technology, data, and analytics into an integrated solution.

About Current Health

Current Health provides the leading FDA-cleared, artificial intelligence (AI)-powered remote patient monitoring platform to help healthcare providers reduce risk, cost and readmissions while improving outcomes. Current Health combines a continuous, ICU-accurate wearable vital signs sensor, connectivity with other devices, symptom chatbot and video visits into a single platform. Powered by advanced analytics, Current Health’s platform offers healthcare providers the real-time insights they need to make proactive and informed decisions about patient care. As a result, providers can improve patient outcomes and experiences, while reducing the cost of healthcare delivery. For more information, visit https://www.currenthealth.com and follow us on Twitter and LinkedIn.

VivaLNK Media Contact:
pr@VivaLNK.com

Current Health Media Contact:
Version 2.0 Communications
Victoria Newell, 617-426-2222
currenthealth@v2comms.com

 

View original content:http://www.prnewswire.com/news-releases/current-health-selects-vivalnk-wearable-temperature-sensor-for-remote-patient-monitoring-301057537.html

SOURCE VivaLNK

Staff

Recent Posts

Castle Biosciences Announces Updates to its Board of Directors

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that…

11 hours ago

Akanda Corp. Announces Closing of Underwritten Public Offering

London, United Kingdom--(Newsfile Corp. - March 27, 2024) - On March 24, 2024, Akanda Corp.…

11 hours ago

Dermata to Present at the Emerging Growth Conference on April 3, 2024

- Dermata to provide a corporate update followed by a live question and answer session…

11 hours ago

CorDx Receives Emergency Use Authorization (EUA) for 10-Min Flu A/B & COVID-19 Test

FDA Grants CorDx Emergency Use Authorization for Multi-Target Rapid Test for Flu A/B & COVID-19SAN…

14 hours ago

Greenway Health and DrFirst Partner to Improve Medication Adherence and Improve Patient Outcomes through Technology

TAMPA, Fla., March 27, 2024 /PRNewswire/ -- Greenway Health, a leading health information technology services provider, announced its strategic…

17 hours ago

NextGen Healthcare Named to Newsweek List of America’s Most Trustworthy Companies for Third Year in a Row

List Based on an Independent Survey of 25,000 U.S. ResidentsREMOTE-FIRST COMPANY/NEW YORK--(BUSINESS WIRE)--#NextGenHealthcare--NextGen Healthcare, a…

17 hours ago